Is OZURDEX approved for CME?: Understanding Specific Indications and Uses
•
6 min read
While cystoid macular edema (CME) can arise from many causes, the FDA approval for the dexamethasone implant OZURDEX is limited to specific underlying conditions. The biodegradable OZURDEX implant is an important tool in treating retinal swelling, but its official use case is narrower than its clinical application suggests.
